Drugs / Sacubitril/Valsartan
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT05243199 | Aug 2020 → Mar 2023 | end stage renal failure, heart failure | Ruijin Hospital | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Sacubitril/Valsartan | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05243199 ↗ |